1.Ciampi E, Uribe-San-Martin R, Cárcamo C, Cruz JP, Reyes A, Reyes D,
Pinto C, Vásquez M, Burgos RA, Hancke J. Efficacy of andrographolide in not
active progressive multiple sclerosis: a prospective exploratory double-blind,
parallel-group, randomized, placebo-controlled trial. BMC neurology. 2020
Dec;20:1-0.

2.Okonogi R, Thampanya V, Okonogi S. Efficacy of Andrographis
paniculata spray in acute pharyngitis: A randomized controlled trial. Drug
Discoveries & Therapeutics. 2023 Oct 31;17(5):340-5.

3.Suriyo T, Pholphana N, Ungtrakul T, Rangkadilok N, Panomvana D, Thiantanawat A, Pongpun W, Satayavivad J. Clinical parameters following
multiple oral dose administration of a standardized Andrographis paniculata
capsule in healthy Thai subjects. Planta medica. 2017 Jun;83(09):778-89.

4.Ali SK, Makeen HA, Khuwaja G, Alhazmi HA, Sharma M, Koty A, Mazahirul I, Parveen H, Mohammed A,
Mukhtar S, Alam MF. Assessment of the phytochemical profile, antioxidant
capacity, and hepatoprotective effect of Andrographis paniculata against
CCl4-induced liver dysfunction in Wistar Albino rats. Medicina. 2023 Jul 6;59(7):1260.

5.Bardi DA, Halabi MF, Hassandarvish P, Rouhollahi E, Paydar M, Moghadamtousi SZ, Al-Wajeeh NS, Ablat A, Abdullah NA, Abdulla MA.
Andrographis paniculata leaf extract prevents thioacetamide-induced liver
cirrhosis in rats. PloS one. 2014 Oct 3;9(10):e109424.

6.Huang Z, Wu Z, Zhang J, Wang K,
Zhao Q, Chen M, Yan S, Guo Q, Ma Y, Ji L. Andrographolide attenuated
MCT-induced HSOS via regulating NRF2-initiated mitochondrial biogenesis and
antioxidant response. Cell Biology and Toxicology. 2023 Dec;39(6):3269-85.